The mitochondria‐targeted anti‐oxidant mitoquinone decreases liver damage in a phase II study of hepatitis C patients

Overview of attention for article published in Liver International, May 2010

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (91st percentile)
High Attention Score compared to outputs of the same age and source (84th percentile)

So far, Altmetric has seen 2 X posts from 1 X users, with an upper bound of 29,011 followers.

@puddleg LOL. Darn placebos... "[MitoQ] decreases liver damage in a phase II study of hepatitis C patients" https://t.co/A48uxBJ46Y

The mitochondria-targeted anti-ox. mitoquinone decreases liver damage in phase II study of hep-C patients https://t.co/fKmkHVY8zF @puddleg

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity.